Hereditary disorders causing a deficiency of s u l f i t e oxidase (SO) activity result in the accumulation of s u l f i t e , sulfocysteine and thiosulfate and a clinical syndrome of seizures, developmental delay, and ectopia l e n t i s . The defect may be in the structural enzyme protein (apoenzyme) of SO or due to the absence of i t s active molybdenum (Mo) cofactor, in which case Mo-dependent xanthine oxidase activity i s also reduced. Study of fibroblast lines of one patient (A) with SO apoenzyme defect and 5 unrelated patients (8-F) with M o cofactor deficiency revealed no detectable SO activity in any case. Complementation t e s t s showed that SO activity was restored when Line B was cocultured with each of 5 other lines. No activity was detected in other pairwise combinations. Complementation occurred without heterokaryon formation, suggesting that the corrective factor may be a diffusible precursor of the cofactor. These findings confirm heterogeneity of SO deficiency; a t least 3 , variants can be distinguished. Line A has a mutation of the structural gene for SO apoenzyme which may have affected the binding of the heme or M o cofactor but i s without effect on i t s antigenicity. Among the cofactor deficient lines, Line B clearly has a defect different from and correctable by the other 4 lines. These 4 could have a comnon defect or non-complementing lesions in the biosynthetic pathway'of the cofactor. Corrplmntation analysis of the urea cycle disorder ASAL deficiency has shown it t o be characterized by striking genetic heterogeneity due t o multiple a l l e l e s a t a single locus, possibly the ASAL structural gene. W e have examined the fibroblast ASAL monomer from 28 patients using denaturing polyacrylamide gel electrophoresis and protein blotting. Liver extracts and nine control fibroblast s t r a i n s had a single protein band of W '49,500 which cross-reacted with an anti-ASAL antisera. A l l 28 mutant s t r a i n s had imnunologically cross-reactive m t e r i a l (CRM) i n the 49,500 region varying from trace t o n o~m l levels. Five mutants with t h e largest anaunt of 49,500 Mnl CRM also had the highest residual enzymz a c t i v i t y q the greatest a b i l i t y t o c o n p l m n t other mutants. In contrast t o controls 27 of the 28 mutants had substantial lower M4 CRM of 42,000, 38,000, 35,000, 34,000 and 30,500. In addition t o the 49,500 W band, several of these bands were a l s o prominent i n the blots of two obligate heterozygote s t r a i n s . Only trace amounts of the lower W bands were seen intermittently i n controls. One mutant had unique bands of W 39,000 and 25,000 suggesting the presence of at--ted polypeptide. These studies provide clear evidence of extensive heterogeneity i n the abundance of the ASAL m n m r ( W 49,500) i n the mutant s t r a i n s , and supporting evidence that kSAL deficiency affects the ASAL structural gene, resulting i n the production of ASAL m n m r s with increased i n vivo l a b i l i t y . GA patients exhibit chorioretinal degeneration and histologic muscle abnormalities.
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Owina to an inherited deficiencv of ornithine aminotransferase, they accumulate ornithine-to levels which are lox normal and well above the Ki of glycine transamidinase, the f i r s t enzyme in the creatine biosynthetic pathway. Previous work utilizing an insensitive assay has shown reduced levels of the creatine ( c r ) presursor guanidinoacetic acid (gaa) in the urine of patients with GA (Sipila e t a l , J.Clin. Invest. 67: 1805 Invest. 67: ,1981 . W e developed a specific HPLC/fluorometric method for measuring these compounds in biologic samples.
The lower limit of detectability for c r i s 0.1 pmol and for gaa 3 pmol. W e found subnormal levels of both c r and gaa in patients yith GA.
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In addition, we found reduced levels of total c r in adult GA skeletal muscle: patients (n.3) mean (range) i s 6.5 nmol/mg prot (5.1-7.8); control (n=3) 31.4 (23.5-42.0). W e conclude from the reduced levels of gaa that c r synthesis i s impaired in GA and that t h i s eventually leads to reduction of tissue levels of c r despite normal dietary intake.
These results support the hypothesis that c r deficiency i s an important pathophysiologic factor in GA. In cystinosis there i s a defect i n cystine efflux from the l y s o s m s which i s expressed i n both cultured fibroblasts and E.B. virus transformed lymphoblasts. Cystine efflux from lysos m s isolated i n Hepes/Sucrose from control lymphoblasts i s s t i m l a t e d by the addition of MgATP, while efflux from l y s o s m s isolated from control fibroblasts i s not. To c l a r i f y the role of ATP and the lysosoml ATPase i n cystine efflux, we determined the pH of lysosomes isolated i n simultaneous experiments fron both c e l l types by measuring the fluorescence of i n t r a l y s o s m l FITCdextran. iIhe pH of lymphoblast l y s o s m s i s 6.5f .05. This i s lowered t o 6.2f.03 by the addition of MgATP t o the incubation buffer. Fibroblast lysosomes have a pH of 5.5r.07 which i s not altered by the addition of MgATF' . However, i f the pH of fibroblast l y s o s m s i s raised by preincubation with KCl, ATP causes acidification t o near-initial values. In both c e l l types, there i s no significant difference jetween cystinotic and control lysosomes i n i n i t i a l pH, a b i l i t y t o use ATP t o produce an acidic pH, o r the m u n t of proton-translocating ATPase activity. Cur interpretation of these data i s that cystine efflux from l y s o s m s requires a highly acidic i n t r a l y s o s m l pH. Since fibroblast lysosomes isolated i n ~epes/Sucrose have a pH of 5.5 independent of ATP addition, cystine efflux i s not stimulated by ATP i n t h i s system. In contrast, lymphoblast lysosomes a r e acidified i n the presence of ATP, explaining the requirement of cystine efflux f o r ATP.
ACHONDROPLASIA D U E TO D N A INSERTION INTO T H E l 784 T Y P E I 1 C O L L A G E N G E N E . C h a r l e s . M . Strom
(Spon. by Lawrence M . G a r t n e r ) U n i v e r s i t y of Chicago, ~r i t z k e r school of Medicine, Department of P e d i a t r i c s , Chicago, IL 60637 A c h o n d r o p l a s t i c dwarfism i s an autosomal dominant d i s o r d e r i n which 90% of c a s e s r e p r e s e n t new mutat i o n s . The m o l e c u l a r mechanisms of t h e d i s r u p t i o n of normal c a r t i l a g e and endochondral bone f o r m a t i o n remain u n e l u c i d a t e d . Type I 1 c o l l a g e n i s t h e major c o l l a g e n o f c a r t i l a g e and p l a y s an i m p o r t a n t r o l e i n s t a b i l i z i n g t h e e x t r a c e l l u l a r m a t r i x .
In t h i s s t u d y , f i b r o b l a s t D N A from a p a t i e n t with c l a s s i c a l s p o r a d i c a c h o n d r o p l a s i a and p e r i p h e r a l white c e l l
DNb from h e r p a r e n t s w i t h normal s t a t u r e were a n a l y z e d . Southern f i l t e r s were p r e p a r e d f o l l o w i n g BamHl d i g e s t i o n and were probed with pgHCol( I I ) a1 , a T o b e t o t h e carboxy p r o p e p t i d e and t r i p l e h e l i c a l r e g i o n of t h e human t y p e I 1 p r o c o l l a g e n gene ( S t r o m , C . and Upholt, W.B., N u c l e i c Acids Res., i n p r e s s ) . The D N A from b o t h p a r e n t s showed only t h e normal 4.2kb band. The a c h o n d r o p l a s t i c DNA, however, showed a f a i n t band a t 4.2kb and a d e n s e r band a t 6.2kb. F u r t h e r a n a l y s i s r e v e a l e d t h a t t h e polymorphic 6.2kb band i s due t o an i n s e r t i o n of D N A s e q u e n c e s c o~p l ementary t o t h e pgHCol(1I)al probe n e a r t h e 3 end of t h e t y p e I 1 c o l l a g e n gene. T h i s i s t h e f i r s t d e m o n s t r a t i o n of t y p e I 1 c o l l a g e n gene changes i n t h e human c h o n d r o d y s t r o p h i e s . In order to define a single major gene defect which could account for the Marfan syndrome (MS) phenotype we used a high frequency EcoRI restriction fragment length polymorphism in the pro 2 ( I ) gene of type I collagen as a marker for genetic linkage studies.
GENETIC LINKAGE STUDIES IN THE MARFAN SYNDROME
The presence or absence of one EcoRI recognition s i t e creates a two a l l e l e system observed a f t e r hybridization with a 6.75kb pro 2 ( I ) genomic probe (Tsipouras e t a l . JCI 72:1262 JCI 72: , 1983 . W e studied affected and unaffected individuals in three families with MS. In family A the segregation of the clinical phenotype was concordant with the segregation of the marker a l l e l e , although random cosegregation could not be excluded due to the small number of informative matings. In family 8 the segregation of the clinical phenotype and marker a l l e l e was discordant. Family C was not informative due t o lack of heterozygosity for the marker a l l e l e . Our data suggest the some variants of M S may be linked t o mutati~ns in or near the pro 2 ( I ) collagen gene. This i s in agreement with the observation that a structural alteration in the pro 2 ( I ) chain of type I collagen results in the M S in one patient (PNAS 78:7745, 1981) . Our data further suggest that M S i s biochemically heterogeneous and that defects in more than one gene may result in the phenotype.
